Managing the security of the global supply chain, and thus, the integrity of global pharmaceutical
trade, remains one of the biggest threats to both patient safety and pharmaceutical profitability.
The growing presence of fraudulent and counterfeit pharmaceutical products continues to undermine
the health and development of regional markets globally. Yet, with so many disparate global points
of weakness and potential attack, it is clear that there is no easy solution.
In this discussion, panelists will examine:
- The role of both public and private sectors in mitigating against illicit pharmaceutical trade
- Cross sector industry perspective on risk mitigation and anti-counterfeit strategies
- Global awareness campaigns and the correlation with pharma industry activities: How can we align messaging and activity, and will it generate greater impact?